287 Does intracoronary infusion of autologous bone marrow stem cells improve left ventrical function in patients with acute myocardial infarction? Results of 6-month follow-up

2005 ◽  
Vol 4 (1) ◽  
pp. 64-65
Keyword(s):  
Myocardial Infarction ◽  
Acute Myocardial Infarction ◽  
Stem Cells ◽  
Bone Marrow ◽  
Autologous Bone Marrow ◽  
Bone Marrow Stem Cells ◽  
Intracoronary Infusion ◽  
Autologous Bone

scholarly journals Autologous bone marrow stem cells to treat acute myocardial infarction: a systematic review

2008 ◽  
Vol 29 (15) ◽  
pp. 1807-1818 ◽  
Author(s):  
Enca Martin-Rendon ◽  
Susan J. Brunskill ◽  
Chris J. Hyde ◽  
Simon J. Stanworth ◽  
Anthony Mathur ◽  
...  
Keyword(s):  
Myocardial Infarction ◽  
Systematic Review ◽  
Acute Myocardial Infarction ◽  
Stem Cells ◽  
Bone Marrow ◽  
Autologous Bone Marrow ◽  
Bone Marrow Stem Cells ◽  
Autologous Bone

Effect of transplantation with autologous bone marrow stem cells on acute myocardial infarction

2013 ◽  
Vol 162 (3) ◽  
pp. 158-165 ◽  
Author(s):  
Chaoquan Peng ◽  
Ke Yang ◽  
Peng Xiang ◽  
Chengxi Zhang ◽  
Liyuan Zou ◽  
...  
Keyword(s):  
Myocardial Infarction ◽  
Acute Myocardial Infarction ◽  
Stem Cells ◽  
Bone Marrow ◽  
Autologous Bone Marrow ◽  
Bone Marrow Stem Cells ◽  
Autologous Bone

Intracavernous application of autologous bone marrow stem cells for medical treatment-refractory erectile dysfunction: A case report

2020 ◽  
Vol 80 (2) ◽  
pp. 1-9
Author(s):  
José Iván Robles-Torres ◽  
Consuelo Mancías-Guerra ◽  
Alejandra Garza-Bedolla ◽  
Lauro Salvador Gómez-Guerra
Keyword(s):  
Stem Cells ◽  
Bone Marrow ◽  
Stem Cell ◽  
Erectile Dysfunction ◽  
Adverse Events ◽  
Clinical Response ◽  
Autologous Bone Marrow ◽  
Bone Marrow Stem Cells ◽  
Autologous Bone

Clinical case description: A 61-year-old man with severe erectile dysfunction related to diabetes mellitus of long duration was treated through intracavernous stem cell application. Transplantation of autologous bone marrow stem cells through a single intracavernous injection was performed. Clinical response, Doppler ultrasound of the penis, and adverse events were evaluated during the 50-week follow-up. The highest clinical response was reported at week 12, but it diminished thereafter. At the end of follow-up, ultrasound identified the presence of neovascularization emerging from the cavernous arteries. Relevance: Numerous preclinical trials have demonstrated efficacy and safety, but there is insufficient clinical evidence showing promising results. Clinical implications: No adverse events were detected, and ultrasound revealed hemodynamic changes that were possibly related to the therapy. The source and dosage of stem cells, as well as subsequent therapeutic applications, pose questions that remain to be answered. Conclusions: Stem cell therapy for erectile dysfunction is a field of research that has sparked interest in numerous scientific groups, but clinical experience is still limited.

Sign in / Sign up

Export Citation Format

Share Document